Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats
- PMID: 2960790
Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats
Abstract
Technetium-99m (99mTc) mercaptoacetylglycylglycylyglycine (MAG3) in high (greater than or equal to 95%) radiochemical purity is prepared from lyophilized kits containing benzoylMAG3, sodium tartrate, lactose, and stannous chloride by adding sodium [99mTC]pertechnetate and heating the contents briefly. Constant-infusion renal whole-blood clearance obtained with [99mTc] MAG3 kits was compared with that obtained with high performance liquid chromatography (HPLC) pure [99mTc]MAG3 and with co-infused iodine-131 (131I) iodohippurate (OIH) in anesthetized rats. Average renal whole-blood clearance of [99mTc]MAG3 from kits was 3.9 +/- 0.4 ml/min/100 g body weight (mean +/- s.e.m. n = 5) and that for HPLC-pure [99mTc]MAG3 was 4.6 +/- 0.3 (n = 3). Renal whole-blood clearance ratios for [99mTc]MAG3 to co-infused iodine-131 (131I) OIH were greater than unity for both kit formulation (1.7 +/- 0.1) and HPLC-pure [99mTc]MAG3 (1.9 +/- 0.2). Differences in these two measures were not significant. Plasma binding (determined from blood drawn at the end of the infusion) of [99mTc]MAG3 prepared from both kits (75 +/- 2%, n = 4) and HPLC-separation (76 +/- 4%) were greater than that of [131I]OIH in corresponding plasma samples (31 +/- 1% and 32 +/- 2%) respectively). Renograms performed in anesthetized rats revealed no statistically significant differences between kit-prepared [99mTc]MAG3 and [131I]OIH in terms of time-to-peak renal activity (5.0 +/- 1.7 min, n = 6; and 2.2 +/- 0.2 min, n = 3, mean +/- s.e.m. for [99mTc]MAG3 and [131I]OIH, respectively), in terms of time to fall to half-maximal activity (15.3 +/- 2.4 min and 9.6 +/- 2.1 min, respectively), or in terms of fraction of peak radioactivity in right kidney (0.53 +/- 0.01 for both substances). To assess possible interference from hepatobiliary uptake and excretion in renal failure, radioactivity in liver regions of interest was followed by gamma camera scintigraphy for 30 min after intravenous injection of [131I]OIH and kit and HPLC-purified [99mTc]MAG3 in anesthetized rats rendered anephric by ligating renal peduncles. Liver activity was 25% of total for both preparations of [99mTc]MAG3 and was 22% of total for [131I]OIH. There were no significant differences among the substances.
Similar articles
-
Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.J Nucl Med. 1988 May;29(5):669-75. J Nucl Med. 1988. PMID: 2967354
-
Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.J Nucl Med. 1986 Jun;27(6):795-803. J Nucl Med. 1986. PMID: 2940350
-
Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.Radiology. 1989 Mar;170(3 Pt 1):721-5. doi: 10.1148/radiology.170.3.2521734. Radiology. 1989. PMID: 2521734
-
Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.Semin Nucl Med. 1992 Apr;22(2):61-73. doi: 10.1016/s0001-2998(05)80082-0. Semin Nucl Med. 1992. PMID: 1534184 Review.
-
99mTc renal tubular function agents: current status.Semin Nucl Med. 1990 Jan;20(1):28-40. doi: 10.1016/s0001-2998(05)80174-6. Semin Nucl Med. 1990. PMID: 2136959 Review.
Cited by
-
What does protein binding of radiopharmaceuticals mean exactly?Eur J Nucl Med. 1990;17(3-4):101-2. doi: 10.1007/BF00811433. Eur J Nucl Med. 1990. PMID: 2149101 No abstract available.
-
A simple two-strip method to determine the radiochemical purity of technetium-99m mercaptoacetyltriglycine.Eur J Nucl Med. 1993 Apr;20(4):334-8. doi: 10.1007/BF00169810. Eur J Nucl Med. 1993. PMID: 8491226
-
Dynamic renal scanning using 99mTc-MAG-3 in man.Eur J Nucl Med. 1989;15(10):635-40. doi: 10.1007/BF00251675. Eur J Nucl Med. 1989. PMID: 2530091
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources